mutLBSgeneDB |
Gene summary for NRXN1 |
![]() |
Basic gene Info. | Gene symbol | NRXN1 |
Gene name | neurexin 1 | |
Synonyms | Hs.22998|PTHSL2|SCZD17 | |
Cytomap | UCSC genome browser: 2p16.3 | |
Type of gene | protein-coding | |
RefGenes | NM_001135659.1, NM_004801.4,NM_138735.2, | |
Description | neurexin Ineurexin-1-beta | |
Modification date | 20141222 | |
dbXrefs | MIM : 600565 | |
HGNC : HGNC | ||
Ensembl : ENSG00000179915 | ||
HPRD : 11858 | ||
Vega : OTTHUMG00000129263 | ||
Protein | UniProt: Q9ULB1 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_NRXN1 | |
BioGPS: 9378 | ||
Pathway | NCI Pathway Interaction Database: NRXN1 | |
KEGG: NRXN1 | ||
REACTOME: NRXN1 | ||
Pathway Commons: NRXN1 | ||
Context | iHOP: NRXN1 | |
ligand binding site mutation search in PubMed: NRXN1 | ||
UCL Cancer Institute: NRXN1 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
![]() |
GO ID | GO Term | PubMed ID |
Top |
Ligand binding site mutations for NRXN1 |
![]() |
LBS | AAchange of nsSNV | Cancer type | # samples | V158 | V158F | LUAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for NRXN1 |
![]() Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
![]() ![]() |
![]() |
![]() Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
![]() |
Top |
Differential gene expression and gene-gene network for NRXN1 |
![]() |
![]() |
Top |
Top |
Phenotype information for NRXN1 |
![]() |
Disease ID | Disease name | # PubMed | Association type |
umls:C0036341 | Schizophrenia | 34 | Biomarker, GeneticVariation |
umls:C0004352 | Autistic Disorder | 21 | Biomarker, GeneticVariation |
umls:C3714756 | Intellectual Disability | 5 | Biomarker |
umls:C1970431 | Pitt-Hopkins syndrome | 4 | Biomarker |
umls:C0023014 | Language Development Disorders | 3 | Biomarker, GeneticVariation |
umls:C0000772 | Abnormalities, Multiple | 1 | Biomarker |
umls:C0008074 | Child Development Disorders, Pervasive | 1 | Biomarker |
umls:C0376634 | Craniofacial Abnormalities | 1 | Biomarker |
![]() |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for NRXN1 |
![]() Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
![]() |
![]() |
Drug status | DrugBank ID | Name | Type | Drug structure |
![]() |
![]() |
![]() |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
Top |
Conservation information for LBS of NRXN1 |
![]() |
LBS | AA sequence | # species | Species |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |